In an ongoing effort to enhance COVID-19 testing capabilities, innovative technologies are continually emerging, as companies leverage advanced techniques to determine virus infections. A recent development from Aspenstate involves a portable X-ray system, called AirTouch, which has received FDA approval, marking a significant step in the realm of digital health diagnostics.
The AirTouch system promises to facilitate rapid chest X-rays for potential COVID-19 patients, significantly streamlining the diagnostic process. Weighing merely 5.5 pounds (2.5 kg), the device resembles a large touchscreen digital camera. Users can capture images at the push of a button, and these images can be wirelessly transmitted to a clinical image storage system or PACS, without requiring a computer. The device’s battery can be fully recharged in just two hours and is capable of taking up to 300 images on a single charge.
Given its portable nature, the AirTouch system has already shown utility in COVID-19 screening operations in South Korea. As stated by David Lee, Vice President and COO of Aspenstate, “Our customers have seen a dramatic increase in their capacity and the ability to transport patients quickly and efficiently.”
Lee further highlighted that the integrated software makes the device user-friendly, enabling its deployment beyond traditional radiology settings. The potential applications for the AirTouch extend to emergency facilities, ambulances, sports medicine, and even veterinary practices, suggesting a broad impact on healthcare delivery amidst the pandemic.
With innovations like the AirTouch, the landscape of COVID-19 diagnostics is evolving rapidly, promising to enhance patient care through advanced technology and improved accessibility.
